Over 80 per cent of men living between 18 and 42 months after a diagnosis of prostate cancer struggle with poor sexual function, yet fewer than half of these men are offered any support to cope with it.
BLOG: This week, the Government unveiled its new 10-year plan for the NHS in England. We scrutinised all 136 pages of it to find out what impacts it could have for men being treated or diagnosed for prostate cancer, and how it could help – or hinder – our own plans.
Belfast City Hospital's £1.5 million robot is set to operate on up to 100 men a year, ending years of men having to travel to England for the procedure and no prostate surgery at all in North Ireland since 2016. We get the reaction from two of our volunteers who have helped us campaign for this welcome breakthrough.
Voted for by her colleagues, patients and their families, Sandie Jones scoops our inaugural award for her extraordinary 20-year career caring for men – from biopsy to post-treatment support. We spoke to her and one of her grateful patients, and find out why we're campaigning for more nurses like Sandie across the UK.
When the Sunday Mirror's editor, Gary Jones, fell ill after a holiday in Spain, it led to a shock diagnosis and urgent surgery to remove his prostate. He recalls the rollercoaster of emotions he experienced since then and explains why his life will never be the same again.
To mark World Mental Health Day, we're highlighting the often overlooked emotional impacts of prostate cancer. We spoke to men with the disease about their mental health challenges and ask what their, our Specialist Nurses' and your tips are for maintaining your emotional wellbeing.
As part of our Research Innovation Awards, we’re funding Professor Claire Lewis at the University of Sheffield to see if it's possible to train men’s own immune systems to fight back at prostate cancer and prevent it from returning. She explains the fascinating 'Trojan horse' science behind this new example of Immunotherapy research.
When Jeremy Nicholl was diagnosed with incurable prostate cancer last year, the 60-year-old photographer decided to film himself undergoing treatment with early docetaxel and hormone therapy, releasing them online as a series called My Beautiful Cancer. We talk to him about why the filming helped him cope with his symptoms and what the public reaction has been to his starkly honest videos.
The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.
A five-year early-stage study of high-intensity focused ultrasound resulted in tumour progression being halted in men with intermediate-risk, localised prostate cancer. But more evidence is needed to prove its benefits hold up against existing treatment options and for all men with the disease.